These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22125312)

  • 1. Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV.
    Detel D; Pugel EP; Pucar LB; Buljevic S; Varljen J
    Exp Physiol; 2012 Apr; 97(4):486-96. PubMed ID: 22125312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.
    Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J
    J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution.
    Detel D; Buljevic S; Pucar LB; Kucic N; Pugel EP; Varljen J
    J Physiol Biochem; 2016 Sep; 72(3):405-19. PubMed ID: 27125676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
    Buljevic S; Detel D; Pugel EP; Varljen J
    J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.
    Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA
    J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV.
    Geier MS; Tenikoff D; Yazbeck R; McCaughan GW; Abbott CA; Howarth GS
    J Cell Physiol; 2005 Aug; 204(2):687-92. PubMed ID: 15754331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
    Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
    Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity.
    Guieu R; Fenouillet E; Devaux C; Fajloun Z; Carrega L; Sabatier JM; Sauze N; Marguet D
    Behav Brain Res; 2006 Jan; 166(2):230-5. PubMed ID: 16154213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
    Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
    Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
    Busso N; Wagtmann N; Herling C; Chobaz-Péclat V; Bischof-Delaloye A; So A; Grouzmann E
    Am J Pathol; 2005 Feb; 166(2):433-42. PubMed ID: 15681827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses.
    Hayakawa Y; Hirata Y; Nakagawa H; Sakamoto K; Hikiba Y; Otsuka M; Ijichi H; Ikenoue T; Tateishi K; Akanuma M; Ogura K; Yoshida H; Ichijo H; Omata M; Maeda S
    Gastroenterology; 2010 Mar; 138(3):1055-67.e1-4. PubMed ID: 19931259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.
    Ban H; Bamba S; Imaeda H; Inatomi O; Kobori A; Sasaki M; Tsujikawa T; Andoh A; Fujiyama Y
    Oncol Rep; 2011 Jun; 25(6):1699-703. PubMed ID: 21431278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of DPP IV/CD26 in cutaneous wound healing process in mice.
    Baticic Pucar L; Pernjak Pugel E; Detel D; Varljen J
    Wound Repair Regen; 2017 Jan; 25(1):25-40. PubMed ID: 27868279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
    Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
    Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an interaction between leptin, T cell costimulatory antigens CD28, CTLA-4 and CD26 (dipeptidyl peptidase IV) in BCG-induced immune responses of leptin- and leptin receptor-deficient mice.
    Rüter J; Hoffmann T; Demuth HU; Moschansky P; Klapp BF; Hildebrandt M
    Biol Chem; 2004 Jun; 385(6):537-41. PubMed ID: 15255186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dipeptidyl peptidase IV in inflammatory bowel diseases (DPP IV/CD26)].
    Pučar LB; Detel D; Varljen J
    Arh Hig Rada Toksikol; 2012 Mar; 63(1):75-100. PubMed ID: 22450208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
    van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
    Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.